Chemoinformaics analysis of 3-Indoleacetonitrile
| Molecular Weight | 156.188 | nRot | 1 |
| Heavy Atom Molecular Weight | 148.124 | nRig | 11 |
| Exact Molecular Weight | 156.069 | nRing | 2 |
| Solubility: LogS | -2.435 | nHRing | 1 |
| Solubility: LogP | 1.791 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 2 | No. of Arom Atom | 9 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 10 |
| nHA | 1 | APOL | 24.2343 |
| nHD | 1 | BPOL | 9.16566 |
| QED | 0.675 |
| Synth | 2.048 |
| Natural Product Likeliness | -0.359 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.016 |
| HIA | 0.005 |
| CACO-2 | -4.465 |
| MDCK | 0.0000203 |
| BBB | 0.957 |
| PPB | 0.6609 |
| VDSS | 1.414 |
| FU | 0.326232 |
| CYP1A2-inh | 0.985 |
| CYP1A2-sub | 0.772 |
| CYP2c19-inh | 0.648 |
| CYP2c19-sub | 0.06 |
| CYP2c9-inh | 0.159 |
| CYP2c9-sub | 0.896 |
| CYP2d6-inh | 0.345 |
| CYP2d6-sub | 0.415 |
| CYP3a4-inh | 0.266 |
| CYP3a4-sub | 0.205 |
| CL | 9.416 |
| T12 | 0.886 |
| hERG | 0.021 |
| Ames | 0.55 |
| ROA | 0.895 |
| SkinSen | 0.298 |
| Carcinogencity | 0.165 |
| EI | 0.98 |
| Respiratory | 0.986 |
| NR-Aromatase | 0.826 |
| Antiviral | No |
| Prediction | 0.745935 |